John Rediske

John Rediske is a Project Lead at Novartis in the areas of immune therapies and oncology biologic therapeutics, Core team member workings towards registration of Kymriah. Obtained Ph.D. in Immunology at Albany Medical College and Post Doc in inflammation at the University of Michigan.